Insmed, Inc. (INSM) — Analysis Summary
Insmed, Inc. (INSM) has a market cap of $23.17B with year-over-year revenue growth of +66.7%. Net margin stands at -210.5%. The stock trades at a P/E ratio of -19.6.
Key Takeaways
- Revenue changed +66.7% year-over-year
- Net margin of -210.5%
- P/E ratio of -19.6
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, INSM posted revenue growth of +66.7% and trades at a P/E of -19.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.